{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:37Z","timestamp":1788225337312,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.isci.2026.116580","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:47:12Z","timestamp":1782964032000},"page":"116580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of hinge domain enhances antitumor efficacy of globo H-targeted CAR-T cells in solid tumor models"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5793-5154","authenticated-orcid":false,"given":"Shance","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116580_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","article-title":"Immunotherapy in hematologic malignancies: achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.isci.2026.116580_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116580_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","article-title":"Challenges and new technologies in adoptive cell therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116580_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.trecan.2024.01.003","article-title":"Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology","volume":"10","author":"Kembuan","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2026.116580_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116580_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/fon-2021-1110","article-title":"The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets","volume":"18","author":"Sigal","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.isci.2026.116580_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1535-7163.MCT-20-0763","article-title":"Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate","volume":"20","author":"Yang","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2026.116580_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000342","article-title":"Globo H-KLH vaccine adagloxad simolenin (OBI-822)\/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study","volume":"8","author":"Huang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116580_bib9","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2217\/fon-2022-0812","article-title":"GLORIA: phase III, open-label study of adagloxad simolenin\/OBI-821 in patients with high-risk triple-negative breast cancer","volume":"18","author":"Rugo","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.isci.2026.116580_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41568-024-00723-5","article-title":"Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance","volume":"24","author":"Wellhausen","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116580_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104180","article-title":"23P Anti-tumor activity of novel Globo-H targeting CAR T cells in cholangiocarcinoma model","volume":"10","author":"Putti","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.isci.2026.116580_bib12","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1158\/1538-7445.AM2023-5946","article-title":"OBI-999, an anti-Globo H antibody drug conjugate, exhibits synergistic anti-tumor effect in combination with pembrolizumab. Poster Presentations at AACR 2023 Annual Meeting","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.isci.2026.116580_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41587-024-02446-2","article-title":"Beyond the blood: expanding CAR T cell therapy to solid tumors","volume":"43","author":"Uslu","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.116580_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226019553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226019553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:53:28Z","timestamp":1788224008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226019553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589004226019553"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116580","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of hinge domain enhances antitumor efficacy of globo H-targeted CAR-T cells in solid tumor models","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116580"}}